New color option for Cocoon Soft Touch frames

Article

San Luis Obispo, CA—Live Eyewear debuted “Inkâ€, a metallic blue finish with black flecking at International Vision Expo East in New York. The new Soft Touch frame color is now available on all Cocoon OveRx sunglasses with an option of gray, amber, copper, or yellow Polaré polarized lens tints.

San Luis Obispo, CA-Live Eyewear debuted “Ink”, a metallic blue finish with black flecking at the International Vision Expo East in New York. The new Soft Touch frame color is now available on all Cocoon OveRx sunglasses with an option of gray, amber, copper, or yellow Polaré polarized lens tints.

According to the company, the dynamic tone takes inspiration from calm and mystical hues and will appeal to both men and women. 

The OveRx sunglass collection, designed to be worn over ophthalmic eyewear frames, incorporates 360° of UV Protection. The Soft Touch finish gently buffers the contact between the wearer's prescription eyewear and the OveRx frame.

For more articles in this issue of InDispensable, click here.

Newsletter

Want more insights like this? Subscribe to Optometry Times and get clinical pearls and practice tips delivered straight to your inbox.

Recent Videos
Dr Luke Lindsell discusses retinal therapy and geographic atrophy at Controversies in Modern Eye Care 2025
Neda Shamie, MD, speaks on cataract and refractive surgery at CIME 2025.
Dr Selina McGee shares thoughts on pharmacological presbyopia correction at Controversies in Modern Eye Care 2025
Paul Hammond, OD, FAAO, presents a poster at ARVO 2025 on the creation of a conversion factor between 2 OCT devices to monitor glaucoma progression
What to know about legislative moves that have been made through May this year.
CIME 25: Dilsher Dhoot, MD, FASRS, is excited about emerging retinal therapies.
Robert Maloney, MD, MA, at the 2025 Controversies in Modern Eye Care meeting
Dr Jacob Lang at the 2025 Controversies in Modern Eye Care meeting
Steven Ferrucci, OD, FAAO, at Controversies in Modern Eyecare 2025
© 2025 MJH Life Sciences

All rights reserved.